Hydrodilatation, corticosteroids and adhesive capsulitis: A randomized controlled trial
<p>Abstract</p> <p>Background</p> <p>Hydrodilatation of the glenohumeral joint is by several authors reported to improve shoulder pain and range of motion for patients with adhesive capsulitis. Procedures described often involve the injection of corticosteroids, to whic...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2008-04-01
|
Series: | BMC Musculoskeletal Disorders |
Online Access: | http://www.biomedcentral.com/1471-2474/9/53 |
_version_ | 1829495729245126656 |
---|---|
author | Juel Niels Sesseng Sølve Tariq Rana Tveitå Einar Bautz-Holter Erik |
author_facet | Juel Niels Sesseng Sølve Tariq Rana Tveitå Einar Bautz-Holter Erik |
author_sort | Juel Niels |
collection | DOAJ |
description | <p>Abstract</p> <p>Background</p> <p>Hydrodilatation of the glenohumeral joint is by several authors reported to improve shoulder pain and range of motion for patients with adhesive capsulitis. Procedures described often involve the injection of corticosteroids, to which the reported treatment effects may be attributed. Any important contribution arising from the hydrodilatation procedure itself remains to be demonstrated.</p> <p>Methods</p> <p>In this randomized trial, a hydrodilatation procedure including corticosteroids was compared with the injection of corticosteroids without dilatation. Patients were given three injections with two-week intervals, and all injections were given under fluoroscopic guidance. Outcome measures were the Shoulder Pain and Disability Index (SPADI) and measures of active and passive range of motion. Seventy-six patients were included and groups were compared six weeks after treatment. The study was designed as an open trial.</p> <p>Results</p> <p>The groups showed a rather similar degree of improvement from baseline. According to a multiple regression analysis, the effect of dilatation was a mean improvement of 3 points (confidence interval: -5 to 11) on the SPADI 0–100 scale. T-tests did not demonstrate any significant between-group differences in range of motion.</p> <p>Conclusion</p> <p>This study did not identify any important treatment effects resulting from three hydrodilatations that included steroid compared with three steroid injections alone.</p> <p>Trial registration</p> <p>The study is registered in Current Controlled Trials with the registration number ISRCTN90567697.</p> |
first_indexed | 2024-12-16T07:17:18Z |
format | Article |
id | doaj.art-6620c967990a4e3f9dfa6235e5ada55a |
institution | Directory Open Access Journal |
issn | 1471-2474 |
language | English |
last_indexed | 2024-12-16T07:17:18Z |
publishDate | 2008-04-01 |
publisher | BMC |
record_format | Article |
series | BMC Musculoskeletal Disorders |
spelling | doaj.art-6620c967990a4e3f9dfa6235e5ada55a2022-12-21T22:39:44ZengBMCBMC Musculoskeletal Disorders1471-24742008-04-01915310.1186/1471-2474-9-53Hydrodilatation, corticosteroids and adhesive capsulitis: A randomized controlled trialJuel NielsSesseng SølveTariq RanaTveitå EinarBautz-Holter Erik<p>Abstract</p> <p>Background</p> <p>Hydrodilatation of the glenohumeral joint is by several authors reported to improve shoulder pain and range of motion for patients with adhesive capsulitis. Procedures described often involve the injection of corticosteroids, to which the reported treatment effects may be attributed. Any important contribution arising from the hydrodilatation procedure itself remains to be demonstrated.</p> <p>Methods</p> <p>In this randomized trial, a hydrodilatation procedure including corticosteroids was compared with the injection of corticosteroids without dilatation. Patients were given three injections with two-week intervals, and all injections were given under fluoroscopic guidance. Outcome measures were the Shoulder Pain and Disability Index (SPADI) and measures of active and passive range of motion. Seventy-six patients were included and groups were compared six weeks after treatment. The study was designed as an open trial.</p> <p>Results</p> <p>The groups showed a rather similar degree of improvement from baseline. According to a multiple regression analysis, the effect of dilatation was a mean improvement of 3 points (confidence interval: -5 to 11) on the SPADI 0–100 scale. T-tests did not demonstrate any significant between-group differences in range of motion.</p> <p>Conclusion</p> <p>This study did not identify any important treatment effects resulting from three hydrodilatations that included steroid compared with three steroid injections alone.</p> <p>Trial registration</p> <p>The study is registered in Current Controlled Trials with the registration number ISRCTN90567697.</p>http://www.biomedcentral.com/1471-2474/9/53 |
spellingShingle | Juel Niels Sesseng Sølve Tariq Rana Tveitå Einar Bautz-Holter Erik Hydrodilatation, corticosteroids and adhesive capsulitis: A randomized controlled trial BMC Musculoskeletal Disorders |
title | Hydrodilatation, corticosteroids and adhesive capsulitis: A randomized controlled trial |
title_full | Hydrodilatation, corticosteroids and adhesive capsulitis: A randomized controlled trial |
title_fullStr | Hydrodilatation, corticosteroids and adhesive capsulitis: A randomized controlled trial |
title_full_unstemmed | Hydrodilatation, corticosteroids and adhesive capsulitis: A randomized controlled trial |
title_short | Hydrodilatation, corticosteroids and adhesive capsulitis: A randomized controlled trial |
title_sort | hydrodilatation corticosteroids and adhesive capsulitis a randomized controlled trial |
url | http://www.biomedcentral.com/1471-2474/9/53 |
work_keys_str_mv | AT juelniels hydrodilatationcorticosteroidsandadhesivecapsulitisarandomizedcontrolledtrial AT sessengsølve hydrodilatationcorticosteroidsandadhesivecapsulitisarandomizedcontrolledtrial AT tariqrana hydrodilatationcorticosteroidsandadhesivecapsulitisarandomizedcontrolledtrial AT tveitaeinar hydrodilatationcorticosteroidsandadhesivecapsulitisarandomizedcontrolledtrial AT bautzholtererik hydrodilatationcorticosteroidsandadhesivecapsulitisarandomizedcontrolledtrial |